My ERA Join ERA

Home | IWG WG

IWG WG

10 / 21 results found

The 2025 KDIGO guideline on the management of nephrotic syndrome in children: a comment of the European Renal Association Immunonephrology Working Group

December 05, 2025

IWG WG

The 2025 update of the KDIGO IgA nephropathy guidelines: An ERA Immunonephrology Working Group perspective

October 22, 2025

IWG WG

Complement activation in secondary thrombotic microangiopathies

May 15, 2025

IWG WG

Malignancies and glomerulonephritis: when to suspect and when to screen?

April 10, 2025

IWG WG

Quo Vadis Standardization of Anti-Nephrin Antibody Detection?

April 03, 2025

IWG WG

Disease-modifying anti-nephropathic drugs (DMANDs) – A definition proposed by the Immunonephrology Working Group (IWG) of the European Renal Association (ERA)

February 08, 2025

IWG WG

Sex dimorphism in kidney health and disease: mechanistic insights and clinical implication

October 28, 2024

IWG WG

Antibody-mediated podocytopathies: a disease entity that implies immunotherapy

July 17, 2024

IWG WG

Immunoengineering for autoimmune-kidney disease

June 21, 2024

IWG WG

Management of adult patients with podocytopathies: an update from the ERA Immunonephrology Working Group

February 10, 2024

IWG WG